Commerzbank Aktiengesellschaft’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.5M | Sell |
444,413
-80,413
| -15% | -$2.14M | 0.26% | 51 |
|
|
2025
Q4 | $13.1M | Buy |
524,826
+7,224
| +1% | +$182K | 0.27% | 55 |
|
|
2025
Q3 | $13.2M | Buy |
517,602
+62,701
| +14% | +$1.55M | 0.27% | 53 |
|
|
2025
Q2 | $11M | Buy |
454,901
+83,531
| +22% | +$1.95M | 0.25% | 54 |
|
|
2025
Q1 | $9.41M | Sell |
371,370
-21,983
| -6% | -$575K | 0.22% | 55 |
|
|
2024
Q4 | $10.4M | Sell |
393,353
-4,032
| -1% | -$109K | 0.25% | 48 |
|
|
2024
Q3 | $11.5M | Buy |
397,385
+55,024
| +16% | +$1.61M | 0.31% | 49 |
|
|
2024
Q2 | $9.58M | Buy |
342,361
+77,073
| +29% | +$2.12M | 0.32% | 43 |
|
|
2024
Q1 | $7.36M | Buy |
265,288
+41,793
| +19% | +$1.16M | 0.24% | 45 |
|
|
2023
Q4 | $6.43M | Buy |
223,495
+13,497
| +6% | +$408K | 0.26% | 42 |
|
|
2023
Q3 | $6.97M | Buy |
209,998
+38,162
| +22% | +$1.35M | 0.33% | 38 |
|
|
2023
Q2 | $6.3M | Buy |
171,836
+97,481
| +131% | +$3.79M | 0.31% | 39 |
|
|
2023
Q1 | $3.03M | Buy |
74,355
+5,100
| +7% | +$220K | 0.16% | 45 |
|
|
2022
Q4 | $3.55M | Sell |
69,255
-31,975
| -32% | -$1.53M | 0.22% | 42 |
|
|
2022
Q3 | $4.43M | Buy |
101,230
+40,965
| +68% | +$1.99M | 0.33% | 35 |
|
|
2022
Q2 | $3.16M | Sell |
60,265
-118,816
| -66% | -$6.05M | 0.22% | 39 |
|
|
2022
Q1 | $9.27M | Sell |
179,081
-55,847
| -24% | -$2.9M | 0.53% | 27 |
|
|
2021
Q4 | $13.9M | Buy |
234,928
+3,293
| +1% | +$163K | 0.79% | 22 |
|
|
2021
Q3 | $9.96M | Buy |
231,635
+64,010
| +38% | +$2.84M | 0.59% | 25 |
|
|
2021
Q2 | $6.56M | Buy |
167,625
+14,270
| +9% | +$555K | 0.42% | 29 |
|
|
2021
Q1 | $5.56M | Buy |
153,355
+28,095
| +22% | +$998K | 0.37% | 32 |
|
|
2020
Q4 | $4.61M | Sell |
125,260
-2,738
| -2% | -$100K | 0.35% | 32 |
|
|
2020
Q3 | $4.46M | Buy |
127,998
+35,251
| +38% | +$1.24M | 0.43% | 29 |
|
|
2020
Q2 | $2.88M | Sell |
92,747
-281,860
| -75% | -$9.58M | 0.31% | 35 |
|
|
2020
Q1 | $11.6M | Sell |
374,607
-706,501
| -65% | -$24.1M | 0.52% | 42 |
|
|
2019
Q4 | $40.2M | Buy |
1,081,108
+170,592
| +19% | +$6.08M | 0.39% | 51 |
|
|
2019
Q3 | $31M | Sell |
910,516
-296,943
| -25% | -$10.8M | 0.24% | 83 |
|
|
2019
Q2 | $49.6M | Sell |
1,207,459
-211,913
| -15% | -$8.41M | 0.39% | 55 |
|
|
2019
Q1 | $57.2M | Sell |
1,419,372
-146,966
| -9% | -$5.89M | 0.52% | 41 |
|
|
2018
Q4 | $64.9M | Buy |
1,566,338
+117,342
| +8% | +$4.87M | 0.66% | 30 |
|
|
2018
Q3 | $60.6M | Buy |
1,448,996
+408,163
| +39% | +$15.7M | 0.53% | 39 |
|
|
2018
Q2 | $35.8M | Buy |
1,040,833
+139,993
| +16% | +$4.78M | 0.34% | 62 |
|
|
2018
Q1 | $30.3M | Buy |
900,840
+194,938
| +28% | +$6.7M | 0.31% | 70 |
|
|
2017
Q4 | $24.3M | Buy |
705,902
+48,104
| +7% | +$1.64M | 0.28% | 82 |
|
|
2017
Q3 | $22.3M | Sell |
657,798
-222,236
| -25% | -$7.14M | 0.29% | 79 |
|
|
2017
Q2 | $28M | Sell |
880,034
-189,618
| -18% | -$5.98M | 0.47% | 50 |
|
|
2017
Q1 | $34.7M | Buy |
1,069,652
+133,472
| +14% | +$4.21M | 0.51% | 42 |
|
|
2016
Q4 | $28.8M | Buy |
936,180
+34,254
| +4% | +$1.05M | 0.42% | 53 |
|
|
2016
Q3 | $29M | Sell |
901,926
-1,298,477
| -59% | -$43.4M | 0.47% | 48 |
|
|
2016
Q2 | $73.5K | Sell |
2,200,403
-159,093
| -7% | -$5.08M | 0.49% | 42 |
|
|
2016
Q1 | $66.4M | Sell |
2,359,496
-215,649
| -8% | -$6.16M | 0.56% | 38 |
|
|
2015
Q4 | $78.9M | Buy |
2,575,145
+1,050,701
| +69% | +$33.1M | 0.61% | 32 |
|
|
2015
Q3 | $45.4M | Sell |
1,524,444
-603,690
| -28% | -$19.4M | 0.34% | 49 |
|
|
2015
Q2 | $67.7M | Sell |
2,128,134
-91,823
| -4% | -$2.99M | 0.36% | 53 |
|
|
2015
Q1 | $73.3M | Sell |
2,219,957
-247,531
| -10% | -$7.87M | 0.44% | 50 |
|
|
2014
Q4 | $72.9M | Sell |
2,467,488
-3,297,659
| -57% | -$94.6M | 0.46% | 51 |
|
|
2014
Q3 | $162M | Buy |
5,765,147
+957,992
| +20% | +$26.9M | 0.65% | 30 |
|
|
2014
Q2 | $135M | Buy |
4,807,155
+382,905
| +9% | +$10.9M | 0.69% | 28 |
|
|
2014
Q1 | $135M | Buy |
4,424,250
+892,477
| +25% | +$26.6M | 0.58% | 27 |
|
|
2013
Q4 | $102M | Buy |
3,531,773
+58,607
| +2% | +$1.71M | 0.5% | 36 |
|
|
2013
Q3 | $94.7M | Sell |
3,473,166
-16,047,560
| -82% | -$437M | 0.47% | 47 |
|
|
2013
Q2 | $519M | Buy |
+19,520,726
| New | +$539M | 2.29% | 5 |
|
Other funds holding PFE
VCM
VPM
Commerzbank Aktiengesellschaft's PFE Position: Q1 2026 in Review
Commerzbank Aktiengesellschaft reduced its Pfizer (PFE) stake by 15% in Q1 2026, selling an estimated $2.14M and leaving 444,413 shares worth $12.5M. The position accounts for 0.26% of the portfolio, ranked #51.
Commerzbank Aktiengesellschaft first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $519M in Q2 2013. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Commerzbank Aktiengesellschaft held 444,413 shares of Pfizer worth $12.5M as of Q1 2026.
- Commerzbank Aktiengesellschaft sold 80,413 Pfizer shares in Q1 2026, an estimated $2.14M.
- Pfizer made up 0.26% of Commerzbank Aktiengesellschaft's portfolio in Q1 2026, its #51 holding.
- Commerzbank Aktiengesellschaft first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
- Commerzbank Aktiengesellschaft's Pfizer position peaked at $519M in Q2 2013.
- 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Commerzbank Aktiengesellschaft's 13F filing for Q1 2026, filed 7 May 2026.